Batches of six different medicines have been pulled off the shelves in Abu Dhabi for failing to meet official specifications.
They include Amydramine paediatric syrup, Moxal Plus tablet, Julphamox 500 mg capsule, Julmentin 2X tablet, Rosuvastatin and Oxaliplatin.
These drugs are prescribed for the treatment of allergies, colon cancer, respiratory tract infections and lowering cholesterol.
The Department of Health (DoH) Abu Dhabi has asked pharmacies and hospitals to return their stock to the supplier.

H.H. Sheikh Hamdan approves Dubai Metro extension to Al Maktoum Airport
UAE President highlights nation's resilience during 'recent challenges'
H.H. Sheikh Mohammed directs tents for 50,000 Gazans facing harsh weather
UAE postpones vehicle licensing limit for residents
New pedestrian bridge links Dubai Mall Metro Station and Coca-Cola Arena
High-achieving Union teams honoured at UAE Government Annual Meetings
Al Gergawi: UAE accelerates development with over AED 4 trillion in projects
Abu Dhabi launches lifestyle programme to help citizens get healthier
5 Esaad cards up for grabs in Dubai Police's 5-week traffic contest
Nominations open for Aster Guardians Global Nursing Award
Dubai Police warns against using phones while driving after four-way crash
RTA opens 1,650-metre Al Khaleej Street Tunnel
Sharjah Ruler allocates AED 4.5 million to stock libraries with book fair collection
UAE expresses solidarity with Egypt over train collision
UAE President sends Diwali greetings in special message
UAE National Guard rescues 22 from cargo ship fire in Sea of Oman
Sheikh Abdullah congratulates Venezuelan FM on appointment
UAE President visits an Emirati family at Abu Dhabi home
